Lung Therapeutics, Inc.

Lung Therapeutics, Inc. is a pharmaceutical company targeting niche, orphan drug indications for lun

is a pharmaceutical company targeting niche, orphan drug indications for lung injury and disease, with an emphasis on fibrosis. Current efforts are focused on a severe complication of pneumonia, called loculated pleural effusion, a debilitating condition where fluid has built up in the chest cavity surrounding the lungs and fibrinous scar tissue in the pleural cavity blocks fluid drainage. Our fir

04/07/2023

Happy World Health Day!!

03/24/2023
02/28/2023

It's great to have new team members. Welcome Sydney Kruger to the Lung team!

11/12/2022

World Pneumonia Day - Let's raise awareness, promote interventions and generate action.

09/25/2022
Timeline photos 09/14/2022

Timeline photos

Please join us for the second annual Interstitial Lung Disease (ILD) Day! For more information and resources about ILD, visit www.ILDDay.org.

09/06/2022

September is Pulmonary Fibrosis Awareness Month

08/22/2022

One week away until the 6th Annual IPF Summit in Boston. Brian Windsor will be speaking on day 2 of the summit (8/31):
• 9:45 am Divulging the Clinical Development of LTI-03 in IPF
Synopsis
- Assessing the "dual threat" of LTI-03: inhibition of the profibrotic process and lung regenerative effects
- Uncovering how biomarkers could be sues to reveal these properties

• 11:00 am Panel Discussion: Reflecting on the Progress & Lessons Learned in IPF Clinical Drug Development - Where Will the IPF Road lead us Next?
Panel Discussion group includes the following:
- Peter Smith, Vice President - Product Development, United Therapeutics
- Brian Windsor, Chief Executive Officer, Lung Therapeutics
- Eric White, Senior Clinical Program Lead, Boehringer Ingelheim

08/01/2022

Lung Therapeutics honors those suffering with lung cancer.

Timeline photos 05/13/2022

The Lung Therapeutics Team is looking forward to . We hope to see you there!

starts today! We're excited to safely reconnect in San Francisco after 2 years!

05/10/2022

Lung Therapeutics is growing. Meet our new members.

04/07/2022

Happy World Health Day from Lung Therapeutics.

Lung Therapeutics Announces Successful Completion of Phase 1a Clinical Trial of LTI-03 in Healthy Volunteers 03/22/2022

Lung Therapeutics Announces Successful Completion of Phase 1a Clinical Trial of LTI-03 in Healthy Volunteers

https://www.businesswire.com/news/home/20220322005536/en/Lung-Therapeutics-Announces-Successful-Completion-of-Phase-1a-Clinical-Trial-of-LTI-03-in-Healthy-Volunteers

Lung Therapeutics Announces Successful Completion of Phase 1a Clinical Trial of LTI-03 in Healthy Volunteers Lung Therapeutics' pioneering compound for the treatment of idiopathic pulmonary fibrosis (IPF), LTI-03, has completed a Phase 1a clinical trial.

Timeline photos 02/23/2022

Timeline photos

Lung Therapeutics, Inc. updated their business hours. 02/14/2022

Lung Therapeutics, Inc. updated their business hours.

Lung Therapeutics, Inc. updated their business hours.

Lung Therapeutics, Inc. updated their phone number. 02/14/2022

Lung Therapeutics, Inc. updated their phone number.

Lung Therapeutics, Inc. updated their phone number.

Lung Therapeutics, Inc. updated their address. 02/14/2022

Lung Therapeutics, Inc. updated their address.

Lung Therapeutics, Inc. updated their address.

Lung Therapeutics breathes easy with $14M Series B | FierceBiotech 06/06/2017

Lung Therapeutics breathes easy with $14M Series B | FierceBiotech

Lung Therapeutics breathes easy with $14M Series B | FierceBiotech Texas startup Lung Therapeutics has got off a $14.3 million Series B round as it eyes the cash boost for its trials in fibrosis, lung injury and disease.

Lung Therapeutics, Inc. Doses First Patient in Phase 1 Clinical Trial of LTI-01 in Australia and New Zealand 05/02/2017

Lung Therapeutics, Inc. Doses First Patient in Phase 1 Clinical Trial of LTI-01 in Australia and New Zealand

Lung Therapeutics, Inc. Doses First Patient in Phase 1 Clinical Trial of LTI-01 in Australia and New Zealand AUSTIN, Texas, March 14, 2017 /PRNewswire/ -- Lung Therapeutics, Inc., a clinical stage pharmaceutical company...

Lung Therapeutics, Inc. 04/29/2016

Lung Therapeutics, Inc.

Over 25 years of research has gone into our lung treatment solutions. At Lung Therapeutics, we won't stop until we have the answer.

Lung Therapeutics, Inc. Lung Therapeutics, Inc. is a pharmaceutical company targeting niche, orphan drug indications for lung injury and disease, with an emphasis on fibrosis.

10/27/2015

Lung Therapeutics, Inc. Chief Scientific Officer Dr. Steven Idell Receives NIH Grant for Phase...

More great news from Lung Therapeutics with NIH funding for Phase 1A/1B Clinical Trial: http://www.lungtx.com/lung-therapeutics-inc-chief-scientific-officer-dr-steven-idell-receives-nih-grant-phase-1a1b-0

Lung Therapeutics, Inc. Chief Scientific Officer Dr. Steven Idell Receives NIH Grant for Phase... Lung Therapeutics, Inc. Chief Scientific Officer Dr. Steven Idell Receives NIH Grant for Phase 1A/1B Clinical Trial of Drug Candidate LTI-01

Untitled album 04/28/2015

Untitled album

Want your business to be the top-listed Business in Austin?
Click here to claim your Sponsored Listing.

Category

Telephone

Address


3801 S. Capital Of Texas Highway, Suite 330
Austin, TX
78704

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Other Biotechnology in Austin (show all)
Oso Vega Oso Vega
600 Congress Avenue
Austin, 78701

We are dedicated to enhancing quality and best practices within the h**p industry by supplying innov

Nanotize Solutions Nanotize Solutions
1708 Timber Ridge Road
Austin

Nanotize Solutions provides innovative and environmentally responsible molecular technologies to mee

Everlum Everlum
Austin, 78717

Everlum is a Rare Disease Lab as a Service. We believe that everyone deserves a cure no matter how b

DiFusion Technologies DiFusion Technologies
624 Headway Circle
Austin, 78754

DiFusion Technologies is a Biotechnology company based in Austin, Texas. We have developed the new Z

Astor Scientific Astor Scientific
5900 Balcones Drive
Austin, 78731

We provide lab and medical supplies to service Houston local community.

Fix Rays LLC Fix Rays LLC
PO. Box5
Austin, 30183

*Repair and maintain medical equipment *Setting up laboratories for research institutes and start up

Aeglea Biotherapeutics Aeglea Biotherapeutics
Austin, 78749

Focusing on modulating the extremes of amino acid metabolism, we use novel engineered human enzymes

Angstrom Bio, Inc. Angstrom Bio, Inc.
1108 Lavaca Street, Suite 110/329
Austin, 78701

Angstrom Massively Parallel Diagnostic: Population-Scale Molecular Diagnostic. Unprecedented Through

Austin Extra-Institutional Science Syndicate Austin Extra-Institutional Science Syndicate
Metaverse
Austin, 78754

Prophase Biostudios is a 501(c)3 non-profit community biotechnology lab based out of Austin, TX OUR

XBiotech XBiotech
5217 Winnebago Lane
Austin, 78744

XBiotech is a fully integrated biopharmaceutical that uses proprietary technology to create True Hum

Brad Meek dba ProtandimRx Brad Meek dba ProtandimRx
5511 Meadow Crst
Austin, 78744

Fight Free Radicals like never before with this Super Antioxidant

Big Fin Scientific Big Fin Scientific
Austin, 78735

Big Fin Scientific creates smart, rugged, digital equipment for Fish Science.